Pomerantz LLP is investigating Astrana Health following a report by Glass House Research that accused the company of relying on aggressive acquisitions and subjective estimates rather than organic growth. Concerns also include a $545 million related-party loan and potential Medicare regulatory risks in 2027. After the report, Astrana's stock dropped over 9%. The investigation aims to determine if Astrana and its executives engaged in securities fraud or other unlawful actions, potentially leading to a class action lawsuit.
Astrana Health, Inc. is under investigation following allegations of aggressive acquisitions and regulatory risks. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 21:12 WIB: out of 128 priced health-sector US stocks, 17 rose and 111 fell. Notable movers include WGS at USD 65.46 with a 1-day change of -4.48% and a typical hold time on Pluang of 19 days, ILMN at USD 256.43 down 4.23% with 93% sell order activity, and RVTY at USD 147.48 down 3.98% with a 12-day typical hold time.
Pacira BioSciences was downgraded from Buy to Hold by Needham following Viatris's announcement to acquire the company for $36.50 per share, valuing it at about $1.65 billion. The deal is expected to close by late 2026 and will enhance Viatris's portf...
Seaport Global increased Shopify's price target from $175 to $180, reflecting an 8.3% upside from the current price of $166.16. Shopify's shares have surged 80% since May, pushing its market value above $205 billion. The rally is driven by a strategi...
Tesco reported earnings per share of $0.69, beating estimates of $0.64, despite revenue falling short at $44.60 billion versus $49.60 billion expected. The UK supermarket raised its full-year adjusted operating profit forecast to £3.15-3.30 billion, ...
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
